27 October 2025

Convatec Group Plc
("Convatec" or "the Company")

Convatec announces that Karim Bitar has passed away

London, UK, 27 October 2025: The Board of Directors of Convatec is very sorry to announce that Convatec's CEO, Karim Bitar, who has been on medical leave of absence since 4 August 2025, has sadly passed away.

Colleagues at Convatec are deeply saddened by this devastating news. Our sincerest sympathies are with Karim's wife and family, and we extend our condolences to them.

As previously announced, interim leadership arrangements remain in place and a further announcement will be made in due course.

This announcement includes inside information as defined in Article 7 of the Market Abuse Regulation No. 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018. The person responsible for making this announcement is James Kerton, Company Secretary, Convatec Group plc: cosec@convatec.com

Media: MediaRelations@convatec.com

Investor Relations: IR@convatec.com

Convatec Group Plc's LEI code is 213800LS272L4FIDOH92

Classification: 2.2 Inside Information disclosed under article 7 of the Market Abuse Regulation

About Convatec

Pioneering trusted medical solutions to improve the lives we touch: Convatec is a global medical products and technologies company, focused on solutions for the management of chronic conditions, with leading positions in Advanced Wound Care, Ostomy Care, Continence Care, and Infusion Care. With more than 10,000 colleagues, we provide our products and services in around 90 countries, united by a promise to be forever caring. Our solutions provide a range of benefits, from infection prevention and protection of at-risk skin, to improved patient outcomes and reduced care costs. Convatec's revenues in 2024 were over $2 billion. The company is a constituent of the FTSE 100 Index (LSE:CTEC). To learn more please visit http://www.convatecgroup.com